{"id":1794,"date":"2015-10-09T18:59:35","date_gmt":"2015-10-10T01:59:35","guid":{"rendered":"https:\/\/drugpolicy.ca\/?p=1794"},"modified":"2021-11-30T08:48:42","modified_gmt":"2021-11-30T16:48:42","slug":"2015_policy_briefs","status":"publish","type":"post","link":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/","title":{"rendered":"Canadian Drug Policy Coalition\/Canadian HIV \/ AIDS Legal Network Policy Briefs"},"content":{"rendered":"<p><strong>Harm Reduction Brief<\/strong><\/p>\n<p>Canada is known around the world as a leader in harm reduction. It is host to the first, and only supervised consumption site in North America, Insite, which has saved lives and helped to build a healthier community in one of the most at-risk neighbourhoods in the county. Unfortunately, the federal government has moved away from harm reduction and more towards a criminal approach to drugs. Of course, there is a way forward. In our policy brief, we make the case that not only should the federal government restore the harm reduction model, but expand upon what is already in place. Please click and read below.<\/p>\n<p><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC-HarmReduction-Brief-Final-Web.pdf\">CDPC-HarmReduction-Brief<\/a>\u00a0English<\/p>\n<p><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC-HarmReduction-Brief-FR-Final-Web.pdf\">CDPC-HarmReduction-Brief<\/a>\u00a0Fran\u00e7ais<\/p>\n<p><strong>Overdose Brief<\/strong><\/p>\n<p>The tragedy of drug overdose has increased dramatically in recent years. The rise of fentanyl, an extremely potent opioid, has dramatically increased overdose deaths in recent months.\u00a0Policy change at the federal level is urgently needed. Fortunately, overdoses are preventable. From allowing for easier access to lifesaving medication such as naloxone, to testing the purity level of street drugs, there are several actions the government can take right now to put an end to these\u00a0avoidable deaths. Our policy brief contains many commonsense policy solutions that the government can enact immediately. Please click and read.<\/p>\n<p><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC-Overdose-Brief-Final-Web.pdf\">CDPC-Overdose-Brief<\/a>\u00a0English<\/p>\n<p><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC-Overdose-Brief-FR-Final-Web.pdf\">CDPC-Overdose-Brief<\/a>\u00a0Fran\u00e7ais<\/p>\n<p><strong>Cannabis Brief<\/strong><\/p>\n<p>Cannabis law is changing around the world. From the United States to Latin America, a wider consensus is growing that cannabis prohibition has failed to prevent both the sale and consumption of the plant for non-medicinal purposes. Public opinion in Canada and worldwide is experiencing a paradigm shift, and the mindset of policymakers needs to change with it. Clearly, an alternative strategy to this broken system needs to be taken seriously. In the following brief, we outline our strategic recommendations on how the federal government can end prohibition, and use its power to begin the process to create a regulatory system that works.<\/p>\n<p><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC-Cannabis-Brief-Final-Web.pdf\">CDPC-Cannabis-Brief<\/a>\u00a0English<\/p>\n<p><a href=\"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC-Overdose-Brief-FR-Final-Web1.pdf\">CDPC-Cannabis-Brief\u00a0<\/a>Fran\u00e7ais<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Harm Reduction Brief Canada is known around the world as a leader in harm reduction. It is host to the first, and only supervised consumption site in North America, Insite, which has saved lives and helped to build a healthier community in one of the most at-risk neighbourhoods in the county. Unfortunately, the federal government [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3136,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","footnotes":""},"categories":[1,18,20,17,26,29,27,30],"tags":[],"class_list":["post-1794","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all","category-cannabis","category-drug-law-reform","category-harm-reduction","category-overdose","category-regulation","category-supervised-consumption-services","category-treatment"],"acf":[],"mb":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Drug Policy Coalition\/Canadian HIV \/ AIDS Legal Network Policy Briefs - Canadian Drug Policy Coalition<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Canadian Drug Policy Coalition\/Canadian HIV \/ AIDS Legal Network Policy Briefs - Canadian Drug Policy Coalition\" \/>\n<meta property=\"og:description\" content=\"Harm Reduction Brief Canada is known around the world as a leader in harm reduction. It is host to the first, and only supervised consumption site in North America, Insite, which has saved lives and helped to build a healthier community in one of the most at-risk neighbourhoods in the county. Unfortunately, the federal government [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Drug Policy Coalition\" \/>\n<meta property=\"article:published_time\" content=\"2015-10-10T01:59:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-30T16:48:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"415\" \/>\n\t<meta property=\"og:image:height\" content=\"415\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\"},\"headline\":\"Canadian Drug Policy Coalition\\\/Canadian HIV \\\/ AIDS Legal Network Policy Briefs\",\"datePublished\":\"2015-10-10T01:59:35+00:00\",\"dateModified\":\"2021-11-30T16:48:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/\"},\"wordCount\":337,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg\",\"articleSection\":[\"All\",\"Cannabis\",\"Drug Law Reform\",\"Harm Reduction\",\"Overdose\",\"Regulation\",\"Supervised Consumption Services\",\"Treatment\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/\",\"name\":\"Canadian Drug Policy Coalition\\\/Canadian HIV \\\/ AIDS Legal Network Policy Briefs - Canadian Drug Policy Coalition\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg\",\"datePublished\":\"2015-10-10T01:59:35+00:00\",\"dateModified\":\"2021-11-30T16:48:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg\",\"contentUrl\":\"https:\\\/\\\/www.drugpolicy.ca\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg\",\"width\":415,\"height\":415},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/2015_policy_briefs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Canadian Drug Policy Coalition\\\/Canadian HIV \\\/ AIDS Legal Network Policy Briefs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"name\":\"Canadian Drug Policy Coalition\",\"description\":\"Change policy. Save lives.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Drug Policy Coalition\",\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"contentUrl\":\"https:\\\/\\\/drugpolicy.ca\\\/wp-content\\\/uploads\\\/2019\\\/04\\\/CDPC-logo-white-on-red-150-dpi.jpg\",\"width\":332,\"height\":333,\"caption\":\"Canadian Drug Policy Coalition\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/dfa227f7f7fb3d70383391c4c01ec657\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/www.drugpolicy.ca\\\/fr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Drug Policy Coalition\/Canadian HIV \/ AIDS Legal Network Policy Briefs - Canadian Drug Policy Coalition","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/","og_locale":"fr_FR","og_type":"article","og_title":"Canadian Drug Policy Coalition\/Canadian HIV \/ AIDS Legal Network Policy Briefs - Canadian Drug Policy Coalition","og_description":"Harm Reduction Brief Canada is known around the world as a leader in harm reduction. It is host to the first, and only supervised consumption site in North America, Insite, which has saved lives and helped to build a healthier community in one of the most at-risk neighbourhoods in the county. Unfortunately, the federal government [&hellip;]","og_url":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/","og_site_name":"Canadian Drug Policy Coalition","article_published_time":"2015-10-10T01:59:35+00:00","article_modified_time":"2021-11-30T16:48:42+00:00","og_image":[{"width":415,"height":415,"url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/#article","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/"},"author":{"name":"admin","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657"},"headline":"Canadian Drug Policy Coalition\/Canadian HIV \/ AIDS Legal Network Policy Briefs","datePublished":"2015-10-10T01:59:35+00:00","dateModified":"2021-11-30T16:48:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/"},"wordCount":337,"commentCount":0,"publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg","articleSection":["All","Cannabis","Drug Law Reform","Harm Reduction","Overdose","Regulation","Supervised Consumption Services","Treatment"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/","url":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/","name":"Canadian Drug Policy Coalition\/Canadian HIV \/ AIDS Legal Network Policy Briefs - Canadian Drug Policy Coalition","isPartOf":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/#primaryimage"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg","datePublished":"2015-10-10T01:59:35+00:00","dateModified":"2021-11-30T16:48:42+00:00","breadcrumb":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/#primaryimage","url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg","contentUrl":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2015\/11\/CDPC_CDPC-LN-Briefs_Blog_415x415px-S.jpg","width":415,"height":415},{"@type":"BreadcrumbList","@id":"https:\/\/www.drugpolicy.ca\/fr\/2015_policy_briefs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drugpolicy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Canadian Drug Policy Coalition\/Canadian HIV \/ AIDS Legal Network Policy Briefs"}]},{"@type":"WebSite","@id":"https:\/\/www.drugpolicy.ca\/fr\/#website","url":"https:\/\/www.drugpolicy.ca\/fr\/","name":"Canadian Drug Policy Coalition","description":"Change policy. Save lives.","publisher":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drugpolicy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.drugpolicy.ca\/fr\/#organization","name":"Canadian Drug Policy Coalition","url":"https:\/\/www.drugpolicy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","contentUrl":"https:\/\/drugpolicy.ca\/wp-content\/uploads\/2019\/04\/CDPC-logo-white-on-red-150-dpi.jpg","width":332,"height":333,"caption":"Canadian Drug Policy Coalition"},"image":{"@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.drugpolicy.ca\/fr\/#\/schema\/person\/dfa227f7f7fb3d70383391c4c01ec657","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88091dfe0f7786637ad63cd9bc22390708578b03d96e777d8ad2685d80b777b9?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.drugpolicy.ca\/fr\/author\/admin\/"}]}},"mfb_rest_fields":["title","yoast_head","yoast_head_json"],"_links":{"self":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/1794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/comments?post=1794"}],"version-history":[{"count":1,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/1794\/revisions"}],"predecessor-version":[{"id":17248,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/posts\/1794\/revisions\/17248"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media\/3136"}],"wp:attachment":[{"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/media?parent=1794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/categories?post=1794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugpolicy.ca\/fr\/wp-json\/wp\/v2\/tags?post=1794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}